Now Medicare will be able to directly negotiate the price of high-cost drugs in Medicare Part B and Part D, as part of the Inflation Reduction Act of 2022 signed by the current president of the United States Joe Biden.
It is expected that by 2023 the first 10 drugs for this negotiation will be announced; Although it should be noted that these prices will not come into effect until 2026.
Medicare will select and negotiate the costs of:
15 Part D drugs in 2025 (effective 2027).
15 Part B and Part D drugs in 2026 (effective 2028).
20 Part B and Part D drugs in 2027 (effective 2029).
20 Part B and Part B drugs in 2028 and every year after
Manufacturers that do not comply with the requirements proposed in the negotiation will be penalized.
With these new changes, you may need to review and compare the costs of the plans
You can call 1(800)204-1297 and we will gladly assist you.
Remember that our service is completely free of charge.
Comments